NASDAQ NMS - GLOBAL MARKET · KNSA
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals International PLC

Biotechnology
$79.18
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
KNSA
Kiniksa Pharmaceuticals International PLC
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for KNSA until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is KNSA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KNSA catalysts
About Kiniksa Pharmaceuticals International PLC
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
366
Country
GB

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$79.18
Last session
Day high
$79.18
Last session
Day low
$79.18
Last session
Previous close
$79.18
52W high
$80.92
-2.15% from high
52W low
$33.04
96% of range
Market cap
$6B
P/E
76.87×
EPS
$1.03
Beta
-0.21
Shares out
78M
Avg volume
670.9K
VWAP
$79.18
Last session
Price history computed in-house
1W
+1.77%
1M
+23.82%
3M
+45.87%
1Y
+134.82%
YTD
+91.95%
SMA 50 $64.58 · above
SMA 200 $50.06 · above
52W position 96%

KNSA overview

Veridion Score
Not reported
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KNSA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KNSA Form 4 filings
Public disclosures

Congress activity in KNSA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for KNSA in the cached public ledger.

Federal contracts

KNSA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KNSA in this window.
Lobbying spend

KNSA lobbying filings, year to date.

Registered lobbying filings matched to Kiniksa Pharmaceuticals International PLC.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KNSA in this window.
Loading news for KNSA
Analyst ratings
Sovereign unlock shows live analyst consensus for KNSA.
Options
Sovereign unlock shows live options positioning for KNSA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.